Leif Bjermer
11 – 20 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
- Contribution to journal › Article
-
Mark
Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects
- Contribution to journal › Article
-
Mark
Treatment Preferences for Acute Allergic Reactions : A Discrete Choice Experiment
- Contribution to journal › Article
-
Mark
EUFOREUM Berlin 2023 : Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
- Contribution to journal › Article
-
Mark
Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
- Contribution to journal › Article
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
- Contribution to journal › Article
